Author: camel

TOKYO, Mar 12, 2025 - (JCN Newswire via SeaPRwire.com) - TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd. (Head Office: Chuo-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), a company engaged in the industrial precious metals business of TANAKA, announces the development of its miniaturized micro profile tape, a next-generation contact for fifth-generation signal relays. It has achieved a minimum width of 0.2 mm, making it the smallest-sized contact tape for fifth-generation signal relays. As relays become smaller, using miniaturized micro profiles can make contacts lighter in weight and suppress bounce and chattering*1 during the opening and closing of contacts. Shipment of this product’s samples is scheduled to start in late March 2025.Miniaturized micro profile (Contact tapes)Micro profiles are ultra-small contacts used in relays and switches, which are the signal control components in electronic devices. Relays are components that take in external electrical signals and carry out the opening and closing or switching of electric circuits. They are widely used in a variety of devices, such as those for communications and facilities and consumer electronics. Contacts embedded in relays responsible for the opening and closing of electric circuits require a high level of reliability as they may cause wrong operation or malfunction of devices if they do not operate properly.In recent years, the miniaturization of electronic devices has led to an increased demand for smaller relays. As relays shrink in size, the weight of the contact that causes bounce during opening and closing has become a significant issue. It is believed that bounce can be minimized by using smaller and lighter contacts. By reducing bounce, electrical signals can be controlled more accurately, which helps to prevent malfunctions in devices. Additionally, smaller contacts contribute to resource savings by reducing the amount of precious metals used, ultimately lowering costs. TANAKA has successfully developed miniaturized contacts through years of research and development in precious metal materials, along with advanced processing technology.Next-Generation Contact for Fifth-Generation Signal RelaysSince entering practical use in the 1830s, relays have been embedded in various electronic devices. Relays that control larger signals using relatively smaller signals (contact opening and closing current of up to 2 A) are called signal relays. Research and development of signal relays and contacts have progressed together with the development of electronic devices, with relays and the contacts inside them becoming smaller.TANAKA has been developing contacts for signal relays since the 1970s, succeeding in developing contacts (0.3 mm tape width) for fourth-generation signal relays in 1998 and contacts (0.25 mm tape width) for fifth-generation signal relays in 2023. Fifth-generation signal relays are used in various fields requiring a high level of reliability, such as communication devices, semiconductor inspection equipment, medical devices, network cameras, smart consumer electronics, and automobiles.History of signal relay contact miniaturization *Based on research by TANAKAMiniaturized contact that is compatible with various materials and methodsThe miniaturized micro profile contact tapes of TANAKA is compatible with various materials and methods. Multilayer contacts using different types of metals are available for a wide range of electric loads and are achieved through employing unique precision bonding techniques.Features of micro profiles (contact tapes)1. Allows multilayer bonding of different types of metals2. Contact tape with excellent bonding strength across its entire length3. Allows reduced sizes of relays and switches4. Various contact materials, shapes and thickness are available to suit a variety of applications.5. Method for forming the gold (Au) layer on the surface can be selected depending on the desired properties (cladding or sputtering)Cladding (left) and sputtering (right)*1 Both bounce and chattering are undesired phenomena in switches and relays, where the unintended opening and closing of contacts may lead to wrong operation. Bounce refers to the phenomenon where, due to shock during contact opening and closing, the contact jumps and repeatedly opens and closes. Chattering refers to the phenomenon of repeated opening and closing due to external vibration and such.About TANAKASince its foundation in 1885, TANAKA has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volume of precious metals it handles. Over many years, TANAKA has manufactured and sold precious metal products for industry and provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and worldwide collaborate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,355 employees, the group’s consolidated net sales for the fiscal year ending December 2023 was 611.1 billion yen.Official Website: TANAKA PRECIOUS METAL TECHNOLOGIEShttps://tanaka-preciousmetals.comProduct inquiriesTANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd.https://tanaka-preciousmetals.com/en/inquiries-on-industrial-products/Press inquiriesTANAKA PRECIOUS METAL GROUP Co., Ltd.https://tanaka-preciousmetals.com/en/inquiries-for-media/Press release: https://www.acnnewswire.com/docs/files/2025312_EN.pdf Copyright 2025 JCN Newswire via SeaPRwire.com.

SINGAPORE, Mar 11, 2025 - (JCN Newswire via SeaPRwire.com) - JCB International Co., Ltd., the international operations subsidiary of JCB Co., Ltd., Japan’s only international payment brand announced premier sponsorship for the 10th edition of Sakura 2025 at Singapore's Gardens by the Bay. The event was opened by Mr. Tan Kiat How, Senior Minister of State, Ministry of National Development & Ministry of Digital Development and Information, Mr. Toru Hotta, Charge d'Affaires of the Embassy of Japan in Singapore, and Mr. Felix Loh, CEO of Gardens by the Bay. JCB's sponsorship is part of its continuing efforts to support local activities and attractions. For example, in 2022, JCB sponsored Singapore's countdown event, Star Island Singapore Countdown Edition 2022-23 Presented by JCB, organised by Avex and held in the prestigious Marina Bay area.Sakura 2025 brings Japan's unique culture and beautiful architectural history to Singapore for residents and visitors from all over the world. As Singapore is a tourism hub, the seasonal highlight enhances the appeal of Gardens by the Bay and Singapore as a whole for tourists."We see Sakura 2025 as an excellent opportunity to showcase Japanese culture and beauty to visitors to Gardens by the Bay. JCB, as the only international payment brand originating from Japan, is one of the sponsors of the event. We also see this as a great opportunity to promote cross-border tourism between Singapore and Japan. Although tourism from Singapore to Japan in 2024 has increased tremendously, we hope that this event will promote a deeper understanding of Japan's interesting culture and further boost tourism to Japan. We also hope that this will raise awareness of JCB's presence and merchant privileges in Singapore, thereby promoting JCB Card usage here," said Hiroko Michishita, Managing Director, JCB International Asia Pacific.During the period of Sakura 2025, banners on selected street lamps, garden banners, and MRT advertisements will feature the event. By pairing this cultural experience with strategic visibility through the event's publicity materials, JCB aims to strengthen its presence in Singapore while encouraging travel and cultural exchange between Japan and Singapore.About JCBJCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 53 million merchants around the world. JCB Cards are now issued mainly in Asian countries and territories, with more than 164 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solution provider, JCB commits to providing responsive and high-quality service and products to all customers worldwide. For more information, please visit: www.global.jcb/en/ContactAnna TakedaCorporate CommunicationsTel: +81-3-5778-8353Email: jcb-pr@info.jcb.co.jp Copyright 2025 JCN Newswire via SeaPRwire.com.

More than 40 percent of the total investment dedicated to the U.S. underpins commitment to scale up the industry to meet surging transformer demandThe U.S. investment includes hiring more than 100 people to expand domestic key component manufacturing to strengthen local supply chainBuilds on the $6 billion USD investment announced in 2024 – the largest in the industry in recent years to respond to the urgent need to upgrade power gridsZurich and Houston, Mar 11, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi Energy announced today at CERAWeek additional major investments of more than $250 million USD by 2027 to expand global production of critical components for transformers. This rapid follow-up to the recently announced $6 billion USD investment across the company portfolio reflects the escalating transformer shortage, which continues to increase.As the electrification of industries, particularly data centers and AI, drives unprecedented demand for electricity, theneed for transformers has surged beyond initial projections. To keep pace with this accelerating demand, Hitachi Energy is expanding its commitment to scale up production and strengthen supply chains in the U.S. and worldwide.These investments bolster Hitachi Energy’s manufacturing capabilities across the U.S., enhancing production capacity at the company’s transformer factories in Virginia, Missouri, and Mississippi. It includes transformer components such as bushings and insulation as Hitachi Energy is a critical supplier to other transformer manufacturers.This pivotal move will also help alleviate the broader, ongoing transformer supply shortage, ensuring increased production capacity and supply-chain resilience. The global investment program, one of the most significant in the industry today, also strengthens Hitachi Energy’s manufacturing capabilities in Asia, South America, and Europe.“The demand for transformers and grid infrastructure is rising at an unprecedented scale and pace,” said AndreasSchierenbeck, CEO of Hitachi Energy. “As the world’s largest transformer manufacturer, we have a responsibility to expand our capacity and accelerate the delivery of transformers and essential components, helping the industry scale up faster and advance critical infrastructure projects.”Transformer investments are part of a broader, multi-billion-dollar investment plan that Hitachi Energy is deploying across its manufacturing, engineering, digital, R&D, and partnership activities. These investments are being rolled out across all major markets globally to enable the company to meet customers’ commitments and market demand. Hitachi Energy is also delivering enhancements in supply chain management, digitalization, and automation, allowing capacity expansion and accelerated speed to market.Transformers are vital to the clean energy transition and enable the efficient transmission and distribution of electricity. They are a key element in integrating renewables, expanding grid interconnections, powering data centers, electrifying transportation, and facilitating the decarbonization of energy systems.Transformer insulation and components, such as bushings, tap-changers, insulation material and parts, and otheraccessories, are essential to the seamless operation of transformers. Asthe world’s largest transformer manufacturer, Hitachi Energy has over 60 transformer factories and 30 service centers worldwide, providing the world's broadest portfolio of transformer insulation and components.Today's investment builds on the $6 billion USD announced in 2024, including $1.5 billion USD specifically allocated to scaling global transformer production. This expansion is essential to meeting growing demand and supporting long-termdecarbonization and electrification efforts.All announced capacity investments include sustainable and state-of-the-art manufacturing technologies for operational efficiency while ensuring high standards of safety and quality. They are advancing the company's efforts to become carbon-neutral in its own operations by 2030 and aim to create positive economic and social impacts in local communities wherever the company works.About Hitachi EnergyHitachi Energy is a global technology leader that is advancing a sustainable energy future for all. We are advancing the world’s energy system to be more sustainable, flexible and secure and we collaborate with customers and partners to enable a sustainable energy future – for today’s generations and those to come. Hitachi Energy has a proven track record and unparalleled installed base in more than 140 countries, serving customers in utility, industry, transportation, data centers and infrastructure sectors. With innovative technologies and services including the integration of more than 150 gigawatts of HVDC links into the power system, we help make the energy value chain more efficient, making electricity more accessible to all. Together with stakeholders across sectors and geographies, we enable the digital transformation required to accelerate the energy transition towards a carbon-neutral future. Headquartered in Switzerland, we employ around 45,000 people in 60 countries and generate business volumes of around $13 billion USD.https://www.hitachienergy.com https://www.linkedin.com/company/hitachienergyhttps://twitter.com/HitachiEnergyAbout Hitachi, Ltd.Hitachi drives Social Innovation Business, creating a sustainable society through the use of data and technology. We solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products. Hitachi operates under the 3 business sectors of “Digital Systems & Services” – supporting our customers’ digital transformation; “Green Energy & Mobility” – contributing to a decarbonized society through energy and railwaysystems, and “Connective Industries” – connecting products through digital technology to provide solutions in variousindustries. Driven by Digital, Green, and Innovation, we aim for growth through co-creation with our customers. The company’s revenues as 3 sectors for fiscal year 2023 (ended March 31, 2024) totaled 8,564.3 billion yen, with 573 consolidated subsidiaries and approximately 270,000 employees worldwide. For more information on Hitachi, please visit the company's website at https://www.hitachi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 10, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that it has been recognized as the 2025 KENKO Investment for Health by Japan’s Ministry of Economy, Trade, and Industry (METI) and the Tokyo Stock Exchange, for the first time as a company strategically carrying out efforts with regard to its employees' health from a management perspective. Eisai has also been certified as an Outstanding Organization of KENKO Investment for Health Program in the large enterprise category (White 500) by METI and the Nippon Kenko Kaigi for the sixth time.The Outstanding Organizations of KENKO Investment for Health Program recognizes outstanding large enterprises, and small and medium-sized enterprises engaging in efforts for health and productivity management by evaluating from a business-management perspective based on the following criteria: “management principles and policies”, “organized structure”, “implementation of systems and measures”, and “evaluation and improvement”. Among the organizations certified as Outstanding Organizations of KENKO Investment for Health, the top 500 in the large enterprise category are recognized as “White 500”. Eisai exceeded the industry average in all criteria, receiving particularly high evaluations in areas such as “information disclosure and dissemination to other companies” (management principles and policies), “lifestyle improvement of employees” and “laying the foundation for the practice of health management” (implementation of systems and measures). The KENKO Investment for Health recognizes outstanding publicly listed companies that are excellent in practicing health management, among companies certified as Outstanding Organizations of KENKO Investment for Health Program. In 2025, 53 companies, including Eisai, were selected from the 3,869 companies that responded to the “Survey on KENKO Investment for Health.”Eisai’s corporate concept is to give first thought to patients and the people in the daily living domain, increasing the benefits that health care provides to them as well as meet their diverse healthcare needs worldwide. Eisai calls this the “human health care (hhc)” concept. Eisai regards its employees as an important stakeholder and asset for the realization of its hhc concept.Eisai issued the Eisai Health Declaration in 2019, and has been making efforts to promote health management. Moreover, to increase human capital value, Eisai made a partial amendment to the Articles of Incorporation at an Ordinary General Meeting of Shareholders in 2022, clearly stating that it will strive to “ensure stable employment”, “respect human rights and diversity”, “provide full opportunities for growth to support self-fulfillment”, and “create an employee-friendly environment”. Eisai has also reinforced its human resource initiatives, including the formulation of an Integrated Human Resource Strategy, with the pillars of “wellbeing, including health, of employees”, “diverse work style”, “development and growth of employees”, and “growth of the organization and businesses”. Since 2023, Eisai has been promoting proactive information disclosure with its Human Capital Report which summarizes Eisai’s human capital initiatives and KPIs linked to its human resource strategies.Through promoting health and productivity management and increasing human capital value, Eisai will continue to increase non-financial value and further contribute to increasing the benefits of patients and the people in the daily living domain.Media Inquiries:Public Relations Department, Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 10, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has announced that it will partner with the Nagasaki University DEJIMA Infectious Disease Research Alliance (Director: Prof. Kouichi Morita) for a research and development (R&D) project with support from the Coalition for Epidemic Preparedness Innovations (CEPI).The CEPI funding, of up to 750 million JPY, will facilitate the composition optimization of "Nanoball," a proprietary vaccine particle covered under Nagasaki University’s intellectual property, and the application of NEC OncoImmunity (NOI)’s artificial intelligence (AI) for the analysis of candidate proteins for a Severe Fever with Thrombocytopenia Syndrome (SFTS) vaccine.The emerging tick-borne virus, a member of the new windowPhenuivirus family, poses a serious public health threat in Japan and wider East Asia.If the project is successful, the platform has the potential to be rapidly adapted to develop vaccine candidates against other disease pathogens, including a novel or as-yet-identified "Disease X" that could cause a serious epidemic or pandemic.Nagasaki University’s innovative technology works by encasing mRNA into Nanoball particles. While mRNA vaccines have been identified as a fast and flexible platform to use in response to infectious disease outbreaks, the next-generation Nanoball technology could help overcome current challenges with the vaccine design to improve its stability and help with the delivery of mRNA to cells to elicit a stronger immune response.The Nanoball design could also enable the vaccine to not require ultra-low temperatures, expanding its access in low-resource areas and hard-to-reach settings, including in low- and middle-income countries who may otherwise lack the infrastructure needed to store and distribute mRNA vaccines in specific conditions.Findings could therefore support the 100 Days Mission, an ambitious goal spearheaded by CEPI and embraced by Japan and other G7 and G20 nations to develop a vaccine against a new virus with outbreak potential in as little as three months."We don’t know where or when the next Disease X will strike – but we know that it is coming," says Dr Richard Hatchett, CEO of CEPI, "As the COVID-19 pandemic shows, we need to be more prepared and act more quickly when responding to an emerging threat. We are delighted to be working with our partners in Japan to carry out this new research looking at whether Nagasaki University’s ‘Nanoball’ technology could provide an improved way of mRNA delivery vehicle, thereby offering faster and more effective vaccine protection in an outbreak."Prof. Takeshi Nagayasu, President of Nagasaki University says, "We are delighted that our SFTSV vaccine, developed using Nagasaki University’s proprietary Nanoball technology, can contribute to CEPI’s efforts and the global 100-Day Mission pursued by leading nations. Rapid vaccine development is crucial in preparing for future pandemics, and we are proud that our research can play a role in this initiative. We look forward to further collaboration in advancing innovative technologies to strengthen global health security and pandemic preparedness."Dr. Saverio Niccolini, Chief Executive Officer, NEC OncoImmunity commented, "NOI is honored to collaborate with CEPI and Nagasaki University in the fight against emerging infectious diseases. We are confident that our advanced AI technology will play a pivotal role in designing a vaccine for the severe fever with thrombocytopenia syndrome (SFTS), a deadly tick-borne pathogen with high mortality rates. This partnership underscores our commitment to harnessing our cutting-edge AI for innovative vaccine development."Key Points1. About SFTSSFTS is a viral infectious disease primarily transmitted to humans through tick bites, which is prevalent in East Asia, including Western Japan. It causes fever, thrombocytopenia (low platelet count), leukopenia (low white blood cell count), and multi-organ failure. Severe cases can result in fatalities.2. Scope of Research & DevelopmentThis project will focus on preclinical research, prior to human clinical trials, to develop a vaccine that can prevent SFTS onset and severe cases.3. Potential ImpactIf successful, this R&D could pave the way for clinical trials and regulatory approval, ultimately leading to widespread vaccination of an SFTS. The project aims to contribute to SFTS countermeasures not only in Japan but across East Asia, helping to save lives that would otherwise be lost to SFTS.The research could also highlight the AI and Nanoball technology as a promising new tool which, with further research, could also help fight other infectious disease threats with epidemic or even pandemic potential. This includes a novel or as-yet-identified Disease X – an emerging threat which could strike in the future and cause a serious humanitarian crisis. COVID-19 was one of the most recent Disease X threats.Overview of the Research and Development InitiativeAbout CEPICEPI is an innovative partnership between public, private, philanthropic, and civil organizations. Its mission is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need. The Government of Japan has been a key supporter of CEPI since its inception and is one of CEPI’s largest government supporters in the world.Funding & AgreementNagasaki University has signed an agreement with CEPI for a three-year, $5 million (approximately 750 million JPY) research and development project. This marks the third CEPI-supported initiative in Japan.Project DetailsThe project aims to develop a vaccine to prevent SFTS onset and severe cases.Nagasaki University Professor Hitoshi Sasaki and team will optimize its current Nanoball composition using Japanese encephalitis virus, an area in which the university has extensive expertise, to develop the new vaccine.NEC OncoImmunity will apply AI-driven genetic sequence analysis to identify potential mRNA vaccine candidates for SFTS.Professor Jiro Yasuda and team will conduct preclinical studies to evaluate the efficacy of the developed SFTS vaccine.Expected OutcomesThis project is expected to lay the groundwork for clinical trials and potential commercialization, providing a lifesaving vaccine to populations at risk of SFTS.The research could also highlight the potential of the AI and Nanoball technology to improve the delivery of mRNA vaccines against other diseases with epidemic and pandemic potential, including known viruses and the hypothetical Disease X.About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 7, 2025 - (JCN Newswire via SeaPRwire.com) - Japan's eight telecommunications companies — Nippon Telegraph and Telephone Corporation, NTT East, NTT West, NTT DOCOMO and NTT Communications (the NTT Group), KDDI Corporation, SoftBank Corp. and Rakuten Mobile — conducted on-site training for the joint use of marine vessels from March 4 to 7, 2025, as part of their cooperative framework launched on December 1, 2024, aimed at ensuring the rapid restoration of communication networks in the event of large-scale disasters. The drill was held in Nagasaki City, Nagasaki Prefecture.The training was conducted on the cable-laying vessel KIZUNA, which is owned by the NTT Group. Mobile network operators conducted training for the installation of shipboard base stations from March 4 to 6, while fixed-line operators conducted drills for the transportation of supplies on March 7. The exercise, which assumed the occurrence of a large-scale disaster, confirmed that the processes for installing base stations, as well as transporting and unloading equipment and supplies, was carried out smoothly.Moving forward, the companies will continue to strengthen inter-operator cooperation and work to ensure the rapid recovery of communication networks during disasters. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 6, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has improved the performance-to-power ratio of 5G mobile core systems (5GC) by more than 6 times, as well as floor space density by 10 times. This was accomplished using Intel Xeon 6 processors with E-Cores under a traffic load and model based on actual commercial traffic patterns.Background:As mobile communications continue to evolve from 5G to 6G, there is a continuing need to handle the ever-increasing volume of mobile traffic. To meet this demand, computing resources in data centers keep increasing, posing challenges on how to handle growing power consumption and floor space. Customers are also demanding improvements in performance per power consumption and floor space density of 5GC, helping to reduce greenhouse gases and improve cost performance.Working jointly with Intel, NEC has achieved a significant improvement in performance per watt and floor space density, verified using the session management function (SMF), which is a core function of NEC’s 5GC, onboarded on Intel Xeon 6 processors with E-Cores.Benefits of NEC's 5GC:NEC's 5GC has advanced parallel computing technology that makes use of multiple CPU cores and features flexible scaling. This enables NEC’s 5GC to make the most of the capabilities of Intel Xeon 6 processors, resulting in significant improvements in performance.Additionally, NEC's 5GC is compatible with a variety of environments, including on-premises used in this verification, as well as public cloud, and can provide the benefits of high performance in any environment.Moving forward, NEC will continue to improve the performance of mobile core systems, aiming to advance networks towards the Beyond 5G/6G era. NEC is committed to contributing to the digital transformation (DX) of telecommunications carriers, improving the end user experience, and developing the mobile network market.About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

- Demonstration of the ability to automatically unload heavy cargo using a winch while in a hovering state, in a presumed isolated area- Demonstration of the ability to use the onboard camera to confirm the status of disaster victims and the damaged areas following a disasterTOKYO, Mar 5, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI), in collaboration with the Japan UAS Industrial Development Association (JUIDA), recently participated in Nankai Rescue 2024, a disaster response training exercise organized by the Japan Ground Self-Defense Force's Middle Army, conducted in preparation for the occurrence of a major earthquake in the Nankai Trough.(1) Training exercises were conducted using unmanned aerial vehicles (UAVs) currently being developed by MHI's Commercial Aviation Systems segment, specifically a small single-rotor unmanned aerial vehicle (hereinafter "small-sized UAV") to assess the status of damage immediately following a disaster, and a medium-sized multirotor unmanned aerial vehicle (hereinafter "medium-sized UAV") to transport heavy cargo to disaster areas. In these drills, both the small and medium-sized UAVs were able to successfully achieve their intended objectives.The training exercise for the transport of heavy cargo to disaster areas using a medium-sized UAV demonstrated that it is possible to transport heavy relief supplies in strong winds, deliver the load to a place that is presumed to be an isolated area, and automatically lower the load using a winch. Specifically, 72 bottles of two-liter plastic bottles of drinking water (weighing 150 kg), provided by Kirin Beverage Co., Ltd. as relief supplies, were transported in strong winds with a maximum wind speed of just under 10 m/s, with the cargo held close to the UAV during takeoff and cruising to reduce wind resistance. For the unloading, while the UAV was in a hovering state, the cargo was lowered by rope with a winch, and disconnected after being placed on the ground. This was the first demonstration confirming that it is possible for a UAV to automatically unload heavy goods using a winch.(2)Training exercises were also conducted to assess the extent of damage immediately following a disaster using a small-sized UAV, demonstrating that it is possible to confirm the status of disaster victims and the damaged areas with the vehicle's onboard camera. The specifications of the drones used in these training exercises are listed below.MHI is leveraging the technologies it has cultivated through aircraft development and manufacturing to develop unmanned aerial vehicles that can be used for both civilian and defense purposes. The company will continue to conduct demonstration tests to improve safety and reliability, applying the knowledge gained to refine the specifications of UAVs. MHI is also pursuing expanded functionality, such as installing satellite communication equipment that enables communication in areas where mobile phones cannot be used, and extending the cruising range of medium-sized UAVs by developing hybrid types.Going forward, MHI aims to take advantage of the characteristics of the small-sized UAV that make it ideally suited for wide-area inspection, patrol, and monitoring missions to conduct wide-area and rapid surveys of damage in the early stages of disasters, and patrols of rivers and roads. In addition, MHI aims to use the medium-sized UAV to transport relief supplies to isolated areas, which is a challenge in the event of frequent disasters. It could also serve as an alternative to trucks and ships to enhance the efficiency of logistics on routes with low cargo volumes, such as remote islands and mountainous areas, and to transport materials for construction work in mountainous areas with limited road access, such as the construction and repair of transmission towers.MHI will continue to work to offer solutions to various challenges by using UAVs, and contribute to the realization of a safe, secure, and comfortable world.Specifications of the Medium-Sized UAV- Payload: 200kg- Cruising range: 15km (prototype), 200km (planned)- Dimensions: Overall length approx. 6m- Motive power: Battery typeHybrid type (power generated by engine) under development- Ease of transport: Can be transported by truck to takeoff/landing points- Additional equipment for demonstration testing:Specifications of the Small-Sized UAV- Single-rotor type that takes wind resistance (wind speed 20 m/s) into consideration- Dimensions: Approx. 2 m x 0.5 m x 0.9 m (length x width x height)- Flight duration: Up to 2 hours- Air speed: Cruising speed of 80 km/h (maximum 130 km/h)- Payload: 7kg (including fuel)- On-board visible light camera- Motive power: Driven by a gasoline engine(An electric motor type was used during this training because of the short flight distance, so the specifications vary slightly from the above.)(1) Nankai Rescue 2024 is a disaster response training exercise conducted in preparation for the occurrence of a major earthquake in the Nankai Trough. Held from January 13-17, 2025, in the Kinki, Tokai, Chugoku, and Shikoku region, it was one of the largest disaster response drills ever conducted, involving approximately 11,300 members of Japan's Ground, Maritime, and Air Self-Defense Forces (GSDF, JMSDF, and JASDF), 32 aircraft, 7 naval vessels, and numerous local governments and private companies, as well as about 210 members of the U.S. Forces in Japan. Various drills using UAVs were held on Awaji Island on January 15.(2) Source: MHIAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 5, 2025 - (JCN Newswire via SeaPRwire.com) - Sato Pharmaceutical Co., Ltd. and Eisai Co., Ltd. announced today that they will conclude their co-promotion based on the co-promotion agreement in Japan regarding the orally-administered antifungal agent NAILIN® Capsules 100 mg (generic name: fosravuconazole) which is manufactured and marketed by Sato Pharmaceutical, as of March 31, 2025. Sato Pharmaceutical and Eisai have concluded a new agreement, under which Eisai will carry out promotional activities for this drug and transfer operations to Sato Pharmaceutical during a transition period from April 1, 2025, to March 31, 2026.NAILIN® Capsules 100 mg have been marketed by Sato Pharmaceutical in Japan since July 2018, with a co-promotion agreement between both companies. However, following the conclusion of the co- promotion agreement and the signing of a new agreement, Sato Pharmaceutical will independently conduct promotions starting from April 2026, following a transition period. Additionally, inrelation to this matter, Sato Pharmaceutical will pay Eisai a lump sum.About fosravuconazoleFosravuconazole is a new oral antifungal component developed by Eisai. Fosravuconazole is a prodrug that improves thesolubility and bioavailability of ravuconazole, the main active ingredient. When administered to humans, it is rapidly converted toravuconazole. Ravuconazole demonstrates antifungal activity by inhibiting ergosterol biosynthesis, a membrane component of fungal cells.In Japan, Seren Pharmaceuticals Inc., which was granted exclusive development and commercialization of this drug by Eisai, has been advancing its development for onychomycosis with Sato Pharmaceutical. Sato Pharmaceutical obtained manufacturing and marketing approval in January 2018, and since July 2018, it has been marketed as Nailin Capsule 100mg.Sato Pharmaceutical and Eisai entered into a license agreement in July 2024, under which Sato Pharmaceutical will undertake the development and commercialization in Asia and Oceania* for fungal diseases.*10 ASEAN member states, Australia, New Zealand, South Korea, TaiwanMedia InquiriesEisai Co., Ltd.Public Relations Department TEL: +81 (0)3-3817-5120Sato Pharmaceutical Co., Ltd. Public Relations Department TEL: +81-(0)3-5412-7354 Copyright 2025 JCN Newswire via SeaPRwire.com.

Smaller "head" than the existing model, more efficient for handling subcompact mini vehicles・Domestic production allows for more focused after-sales service, as well as customization in a timely manner to meet customer needsTOKYO, Mar 4, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries Machinery Systems (MHI-MS), a part of Mitsubishi Heavy Industries (MHI) Group, has finalized domestic development of an autonomous car and vehicle transportation and storage system (hereafter referred to as "a vehicle transport robot") to move automobiles autonomously, and has started trial operations and endurance tests at its production plant.MHI-MS launched a collaborative project in 2021 with its partner Stanley Robotics (SR), a French venture firm, with the intention of importing the robots from France and marketing them domestically. It was later decided to produce a domestic model with Japanese specifications, allowing for more focused after-sales service in Japan, as well as customization in a timely manner to meet customer needs. With the switch to a domestic production policy, MHI-MS is pursuing measures for domestic production, including submitting applications and registering core patents in Japan.(Note1) The Japan market model has a smaller "head" than the existing model, this makes smaller vehicles easier to handle. In addition, at the customer's request, MHI-MS provides a "dress-up service" where the exterior of the head can be customized based on the customer's preference.MHI-MS has established a network of about 100 maintenance and other service bases in Japan. This hub network can also be used to provide service for vehicle transport robots. The adoption of domestic production will allow MHI-MS to provide "Made in Japan" quality with prompt after-sales service.Utilizing these robots for automated transport of finished vehicles(Note2) will greatly improve the work environment for workers engaged in vehicle transport on a regular basis, even in bad weather, extreme heat, and other harsh environments, while also responding to the demands of the logistics industry such as DX (digital transformation) and efficiency improvement.For automated valet parking(Note3) at commercial facilities, the robot will park the car in a vacant space, making it possible to turn the distant parking spaces that people tend to avoid into "close" parking spaces. It also eliminates the problem of drivers being distracted while looking for a vacant space, and causing an accident due to inattention. Further, CO2 emissions from driving vehicles through the site are suppressed, contributing to the realization of a society that is friendly to both people and the planet.Going forward, MHI-MS, as a pioneer in vehicle transport robots in Japan, will combine this innovative technology with the advanced intelligent transportation systems including traffic flow control technology, unmanned system monitoring and EV operation management technology developed by MHI Group to provide services that meet a wide range of customer needs.(1) See the following press release regarding the domestic registration of core patents. www.mhi.com/jp/news/24091101.html (Japanese)(2) The system can operate 24 hours a day year-round in automobile factories, ports, motor pools, and other compounds where vehicles need to be moved, solving the problem of a shortage of skilled drivers while at the same time delivering safe transport at low cost.(3) When the driver stops at a designated berth close to the facility, instead of having to find a parking space on their own, the vehicle transport robot moves the vehicle to a vacant space, taking over parking on behalf of the driver. The process is reversed when retrieving the vehicle, with the robot transporting the vehicle back to the berth at the time specified by the driver in advance using the smartphone app. For drivers, there is no need to find a parking space or park, and no concerns about brushing against the adjacent car when opening the door. For more information on the demonstration test of automated valet parking conducted at a commercial facility in Japan, see the following press releases. www.mhi.com/news/220613.htmlhttps://www.mhi.com/news/221118.htmlAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO and CAMBRIDGE, Mass., Mar 4, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc. announced today that the Therapeutic Goods Administration (TGA) of Australia has confirmed the initial decision to decline the approval of humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody lecanemab (generic name) as a treatment for early Alzheimer’s disease (AD) (mild cognitive impairment due to AD and mild AD dementia).In October 2024, the TGA made the decision not to register lecanemab in Australia for the treatment of patients with early AD. In December 2024, Eisai requested reconsideration of the decision, proposing to the TGA the same apolipoprotein E4 (ApoE4) noncarrier and heterozygote indication that was agreed by the Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA). In the course of the reconsideration of the initial decision, the TGA proposed an alternative narrow therapeutic indication only for ApoE4 noncarriers as an increasing number of ApoE4 alleles is a potential risk factor for ARIA. They did not agree that safety has been established for ApoE4 heterozygotes. Eisai proposed alternative indications, one of which was to maintain the ApoE4 noncarrier and heterozygote indication, but with heterozygotes treated in specialist centers and supervised by physicians with expertise in treatment of AD and monitoring for ARIA; however, the TGA rejected our proposal. “We are extremely disappointed and surprised by the TGA’s decision and understand that the AD community in Australia may also feel disheartened, especially given that eleven countries and regions across the globe have granted marketing authorization. We tried earnestly to reach a compromise with the TGA on an indication that would adequately represent the data in the application but were unfortunately unsuccessful at this time,” said Lynn Kramer, M.D., Chief Clinical Officer at Eisai. “The TGA proposed a narrow indication that would limit access to only ApoE4 noncarriers. This indication would deny approximately two-thirds (~70%) of all potentially eligible patients access to a treatment that could slow the progression of AD. Eisai believes ApoE4 heterozygote carriers should at least also have access to lecanemab given the similar benefit-risk profile to the noncarrier population. Therefore, we could not accept this restrictive indication as it is not patient-centric. Given this outcome, we are deeply concerned that Australians living with Alzheimer’s disease will not have access to a treatment that slows the progression of early Alzheimer’s disease by targeting its underlying causes. Eisai remains committed to ensuring eligible Australians with early Alzheimer’s disease can access lecanemab and is exploring options to achieve this, including potentially seeking review by the Administrative Review Tribunal.”In Australia, the number of people living with dementia was estimated to be approximately 411,000 in 2023, and is reported to increase to approximately 849,000 by 2058.1 AD is considered the most common cause of dementia, typically accounting for 60-70% of cases.2 AD progresses over time in stages with increasingly severe symptoms that greatly impact not only those who are living with AD, but also their loved ones, care partners and society. There is a significant unmet need for new treatment options that slow down the progression of AD from its early stage.=Aβ which is involved in the onset of AD, gradually aggregates in the brain 15 to 20 years before symptoms appear, eventually forming insoluble plaques, a pathological feature of AD. AD is a progressive, relentless disease caused by a continuous underlying neurotoxic process that begins before and continues after plaque removal.3,4,5 Only lecanemab works to fight AD in two ways: continuously clearing protofibrils* ,the most toxic Aβ species, and rapidly clearing plaque. This mechanism has been shown to reduce the rate of disease progression and to slow cognitive and functional decline. Lecanemab has been approved in the U.S., Japan, China, South Korea, Hong Kong, Israel, the United Arab Emirates, the United Kingdom, Mexico, Macau and Oman. Regulatory filings for the treatment have been made in the EU and 17 other countries and regions. In the EU, in February 2025, the Committee for Medicinal Products for Human Use reaffirmed its positive opinion for lecanemab in early AD, adopted in November 2024, and the European Commission is proceeding with the decision-making process for lecanemab’s marketing authorization.Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority.*Protofibrils are believed to contribute to the brain injury that occurs with AD and are considered to be the most toxic form of Aβ, having a primary role in the cognitive decline associated with this progressive, debilitating condition.6Protofibrils cause injury to neurons in the brain, which in turn, can negatively impact cognitive function via multiple mechanisms, not only increasing the development of insoluble Aβ plaques but also increasing direct damage to brain cell membranes and the connections that transmit signals between nerve cells or nerve cells and other cells. It is believed the reduction of protofibrils may prevent the progression of AD by reducing damage to neurons in the brain and cognitive dysfunction.7About lecanemabLecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).Lecanemab is approved in the U.S.,8 Japan,9 China,10 South Korea,11 Hong Kong,12 Israel,13 the United Arab Emirates,14the United Kingdom,15 Mexico16, Macau and Oman. Eisai has submitted applications for approval of lecanemab in 17 countries and regions. In the EU, in February 2025, the Committee for Medicinal Products for Human Use reaffirmed its positive opinion for lecanemab in early AD, adopted in November 2024, and the European Commission is proceeding with the decision-making process for lecanemab’s marketing authorization. In January 2025, the supplemental Biologics License Application (sBLA) for intravenous (IV) maintenance dosing of the treatment was approved in the U.S. After an 18 months initiation phase with once every two weeks of dosing, a transition to the maintenance dosing regimen of 10 mg/kg once every four weeks or continuing 10 mg/kg once every two weeks may be considered. Additionally, the U.S. Food and Drug Administration (FDA) accepted Eisai’s Supplemental Biologics License (BLA) for the LEQEMBI subcutaneous autoinjector for weekly maintenance dosing in January 2025 and set a PDUFA action date for August 31, 2025.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.About the Collaboration between Eisai and Biogen for ADEisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisai serves as the lead of lecanemab development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority.About the Collaboration between Eisai and BioArctic for ADSince 2005, Eisai and BioArctic have had a long-term collaboration regarding the development and commercialization of AD treatments. Eisai obtained the global rights to study, develop, manufacture and market lecanemab for the treatment of AD pursuant to an agreement with BioArctic in December 2007. The development and commercialization agreement on the antibody lecanemab back-up was signed in May 2015.About Eisai Co., Ltd.Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), by working on various activities together with global partners.For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai. Co., Ltd.), us.eisai.com (for U.S. headquarters: Eisai, Inc.) or www.eisai.eu (for Europe, Middle East, Africa, Russia, Australia and New Zealand headquarters: Eisai Europe Ltd.), and connect with us on X (global and U.S), LinkedIn (for global, U.S.and EMEA) and Facebook (global).About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.The company routinely posts information that may be important to investors on its website at www.biogen.com. Follow Biogen on social media – Facebook, LinkedIn, X, YouTube Biogen Safe HarborThis news release contains forward-looking statements, including about the potential clinical effects of lecanemab; the potential benefits, safety and efficacy of lecanemab; potential regulatory discussions, submissions and approvals and the timing thereof; the treatment of Alzheimer's disease; the anticipated benefits and potential of Biogen's collaboration arrangements with Eisai; the potential of Biogen's commercial business and pipeline programs, including lecanemab; and risks and uncertainties associated with drug development and commercialization. These forward-looking statements may be accompanied by such words as “aim,” “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “hope,” “intend,” “may,” “objective,” “plan,” “possible,” “potential,” “predict,” “project,” “prospect,” “should,” “target,” “will,” “would,” and other words and terms of similar meaning. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early-stage clinical trials may not be indicative of full results or results from later stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements. Given their forward-looking nature, these statements involve substantial risks and uncertainties that may be based on inaccurate assumptions and could cause actual results to differ materially from those reflected in such statements. These forward-looking statements are based on management's current beliefs and assumptions and on information currently available to management. Given their nature, we cannot assure that any outcome expressed in these forward-looking statements will be realized in whole or in part. We caution that these statements are subject to risks and uncertainties, many of which are outside of our control and could cause future events or results to be materially different from those stated or implied in this document, including, among others, uncertainty of long-term success in developing, licensing, or acquiring other product candidates or additional indications for existing products; expectations, plans and prospects relating to product approvals, approvals of additional indications for our existing products, sales, pricing, growth, reimbursement and launch of our marketed and pipeline products; our ability to effectively implement our corporate strategy; the successful execution of our strategic and growth initiatives, including acquisitions; the risk that positive results in a clinical trial may not be replicated in subsequent or confirmatory trials or success in early stage clinical trials may not be predictive of results in later stage or large scale clinical trials or trials in other potential indications; risks associated with clinical trials, including our ability to adequately manage clinical activities, unexpected concerns that may arise from additional data or analysis obtained during clinical trials, regulatory authorities may require additional information or further studies, or may fail to approve or may delay approval of our drug candidates; the occurrence of adverse safety events, restrictions on use with our products, or product liability claims; and any other risks and uncertainties that are described in other reports we have filed with the U.S. Securities and Exchange Commission. These statements speak only as of the date of this press release and are based on information and estimates available to us at this time. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove inaccurate, actual results could vary materially from past results and those anticipated, estimated or projected. Investors are cautioned not to put undue reliance on forward-looking statements. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and in our subsequent reports on Form 10-Q and Form 10-K, in each case including in the sections thereof captioned “Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in our subsequent reports on Form 8-K. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements whether as a result of any new information, future events, changed circumstances or otherwise.References(1) Dementia in Australia https://www.aihw.gov.au/reports/dementia/dementia-in-aus/contents/population-health-impacts-of-dementia/prevalence-of-dementia(New Window)(2) World Health Organization. Dementia Fact Sheet. March 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/dementia(New Window).(3) Eisai presents full results of lecanemab Phase 3 confirmatory Clarity AD study for early Alzheimer's disease at Clinical Trials on Alzheimer's Disease (CTAD) conference. Available at: https://www.eisai.co.jp/news/2022/news202285.html(New Window)(4) van Dyck, H., et al. Lecanemab in Early Alzheimer’s Disease. New England Journal of Medicine. 2023;388:9-21. https://www.nejm.org/doi/full/10.1056/NEJMoa2212948(New Window).(5) Hampel H, Hardy J, Blennow K, et al. The amyloid-β pathway in Alzheimer’s disease. Mol Psychiatry. 2021;26(10):5481-5503.(6) Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12:3451. doi:10.1038/s41467-021-23507-z(7) Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.(8) U.S. Food and Drug Administration. 2023. FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval. Last accessed: October 2024.(9) Reuters. 2023. Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen. Last accessed: October 2024.(10) The Pharma Letter. 2024. Brief - Alzheimer drug Leqembi now approved in China. Last accessed: October 2024.(11) Pharmaceutical Technology. 2024. South Korea's MFDS approves Eisai-Biogen's LEQEMBI for Alzheimer's. Last accessed: October 2024.(12) Pharmaceutical Technology. 2024. Hong Kong approves Leqembi for Alzheimer's treatment. Last accessed: October 2024.(13) BioSpace. 2024. Leqembi approved for the treatment of Alzheimer's disease in Israel. Last accessed: October 2024.(14) United Arab Emirates Ministry of Health & Prevention. 2024. Registered Medical Product Directory. Leqembi. Last accessed: October 2024.(15) BioSpace. 2024. Leqembi authorized for early Alzheimer's disease in Great Britain. Last accessed: October 2024.(16) COFEPRIS authorizes innovative treatment for Alzheimer’s patients. Available at: https://bit.ly/3OKks6Y(New Window). Last accessed: December 2024.MEDIA CONTACTSEisaiEisai Co., Ltd.Public Relations DepartmentTEL: +81 (0)3-3817-5120Eisai Europe, Ltd.(UK, Europe, Australia, New Zealand and Russia)EMEA Communications Department+44 (0) 797 487 9419Emea-comms@eisai.netEisai Inc. (U.S.)Libby Holman+1-201-753-1945Libby_Holman@eisai.comEisai Co., Ltd.Public Relations DepartmentTEL: +81 (0)3-3817-5120Eisai Europe, Ltd.(UK, Europe, Australia, New Zealand and Russia)EMEA Communications Department+44 (0) 797 487 9419Emea-comms@eisai.netEisai Inc. (U.S.)Libby Holman+1-201-753-1945Libby_Holman@eisai.comBiogen Inc.Jack Cox+ 1-781-464-3260public.affairs@biogen.com Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, March 4, 2025 - (JCN Newswire via SeaPRwire.com) - Prideone Entertainment Co., Ltd. (Headquarters: Shibuya, Tokyo; CEO: Yasushi Akutagawa) has announced the concept for a new film tentatively titled "Fellers" to mark the 80th anniversary of the post-war era.Akutagawa said, "Fellers is an epic historical spectacle that looks behind the scenes of history from the perspective that it was an American officer, Bonner Fellers, and a group of Christians who saved the Emperor immediately after World War II."Akutagawa, who was the original planner and producer of the 2012 American-Japanese film Emperor (with a production budget of 3 billion yen), also focused on Bonner Fellers in that film. However, various interpretations were incorporated, and the final cut differed considerably from the original idea. The film became a love story between Bonner Fellers, played by Matthew Fox, and an imaginary Japanese lover.In response, various individuals, including Yoshiko Isshiki, former chairperson of Keisen Women's School, strongly suggested that a true-to-history depiction of Fellers be made in this 80th year since the end of the war. This led Akutagawa to create a new film from the fresh perspective. A Japanese director has been chosen for the project, and an original script based on historical facts has already been completed.Post-war Japan began on August 30, 1945, when General Douglas MacArthur, the Supreme Commander of the Allied Powers, landed in Japan and started the full-scale American occupation. MacArthur initiated mass arrests of war criminals and began activities to prosecute them. In the United States, there were strong calls from both the government and public to prosecute the Emperor. On the other hand, MacArthur considered the construction of an "anti-communist bulwark" in the Far East to be of utmost importance. He also eyed a future political career and a potential presidential run, so he felt that he needed to achieve success in post-war governance of Japan at all costs. From this viewpoint, he believed that arresting and executing the Emperor would gain him popular support. MacArthur ordered his subordinates to gather evidence that the Emperor had played a decisive role in Japan’s decision to go to war, including the attack on Pearl Harbor. Meanwhile, Bonner Fellers, an American officer with a deep knowledge of Japan, was tasked by MacArthur to investigate. Fellers, who had become acquainted with Yuri Isshiki before the war, was persuaded by the writings of Lafcadio Hearn, a renowned writer he was introduced to by Yuri, and believed that the Emperor should not be executed. Fellers immediately began searching for the whereabouts of Yuri and her mentor, Michi Kawai. This marked the beginning of a grand political drama and historical spectacle that would lay the foundations for what is now modern Japan. Had these events not unfolded as they did, Japan as we know it might not have existed.Currently, the project is progressing with filming planned for 2027 (in Japan and New Zealand) and release in the fall of 2028. Prideone Entertainment is forecasting a production budget of 4 billion yen, with an additional 1 billion yen for prints and advertising, and is seeking financing options.About the Producer and Executive Producer, Yasushi Akutagawa:Born April 3, 1956, in Kumamoto City, Kumamoto Prefecture. He graduated from the Film Department of the College of Art at Nihon University. Akutagawa started making 8mm films while attending Kumamoto Prefectural Seiseiko High School and decided to pursue a career in film production at university. After graduation, he worked at a major advertising agency before founding Prideone Entertainment Co., Ltd. Since then, he has been involved in producing a wide range of projects in film, television, theater, and radio.Notable Works:- 1991: Futari (Starring: Hikari Ishida) Directed by Nobuhiko Obayashi- 1995: Ashita (Starring: Kaori Takahashi, Yasufumi Hayashi) Directed by Nobuhiko Obayashi- 1998: Kaze no Uta ga Kikitai (Starring: Ryo Amamiya, Yuri Nakae, Tokyo International Film Festival Special Invitation) Directed by Nobuhiko Obayashi- 1999: Ano Natsu no Hi (Starring: Keiju Kobayashi, Yubari International Fantastic Film Festival Special Invitation) Directed by Nobuhiko Obayashi- 2000: Den'en no Ytsu (Starring: Tomokazu Miura, Mitsuko Baisho, Tokyo International Film Festival Special Invitation) Directed by Keisuke Kawahara- 2013: Emperor (Starring: Matthew Fox) Directed by Peter WebberFor inquiries:Prideone Entertainment Co., Ltd.https://yasushi-akutagawa.studio.site/PR: Tsukiokaakidiginfo@gmail.com Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - NTT Corporation (NTT) and NTT DOCOMO, INC. announced today that they have successfully demonstrated the effectiveness and feasibility of In-Network Computing (INC),*1 an architecture that integrates and coordinates computing resources for services such as AI and mobile networks to enable end-to-end quality control, ensuring low latency and bandwidth usage. The demonstration was based on the “Inclusive Core”*2 concept for the 6G/IOWN era originally announced by NTT Corporation in a press release issued in October 2023.During this demonstration, the GSMA-defined Open Gateway*3 / CAMARA API*4 was utilized to develop and implement technologies for controlling network routing based on mobile network conditions. Additionally, new technologies were developed and implemented that enable connection and coordinated control between user communication devices and servers positioned near the user. These will allow on-demand computing services to be provided according to user needs. As a result, the demonstration confirmed that quality requirements spanning both network and computing domains can be rapidly achieved through API control based on user requests. Application of the INC architecture in real-time video data transmission and AI analysis showed that it could achieve accuracy of 90%, which is the AI model's performance limit.This proof of concept was conducted in collaboration with Nokia Corporation. The results will be showcased at Nokia's booth during Mobile World Congress Barcelona 2025, being held from March 3 to 6, 2025, where it will be presented as an example of next-generation network architecture.1. BackgroundDiscussions on international standardization for 6G networks are underway among various countries and organizations. 3GPP, a standardization body in which leading global telecom operators, network vendors and research institutions are participating, plans to commence the development of technical specifications such as architecture and protocols this year. Among the anticipated 6G use cases are new services such as immersive XR, artificial intelligence / machine learning, and sensing. To deliver these services without compromising performance, 6G-era networks will need to accelerate not only conventional communication processes but also the data processing of applications.In response to these challenges, and in the context of international standardization discussions, NTT and DOCOMO, along with many other companies, are considering INC as a core network technology to support 6G-era services. Another key feature of INC is its capability to facilitate the use of 6G services even on simplified devices, by supporting computational processing within the network.2. ISAP*5 OverviewNTT and DOCOMO are dedicated to the research and development of ISAP as the base platform for INC. ISAP is a platform that integrates with mobile networks to deliver computing services, and features the following technical characteristics:- It allows the configuring of computing services in response to each device's mobile network connection status.- It adapts computing services based on changes in cloud-based service usage.- It enables the controlling of computing functions in line with the operational state and attributes of both the mobile network and cloud-based services.3. INC architecture and expansion of existing architecture specificationsTraditionally, mobile networks have focused on managing device connectivity and mobility, primarily handling lower-layer connections from user terminals, through the mobile communication system, to external networks. However, with the evolution and expansion of high-performance services such as XR and edge computing, there is growing demand for higher-layer or application-specific requirements in mobile networks, a trend that is expected to become even more pronounced in the 6G era. Against this backdrop, NTT and DOCOMO have proposed an INC architecture that integrates computing functions into the User Plane Function (UPF).*6 Using an API to interface with core network control, NTT and DOCOMO explored methods to simultaneously set up computing functions and control device network connectivity, identifying necessary specification enhancements.The proposed architecture has three highlights:1. It derives and resolves control policies for communication and computation based on a service attributes and requirements profiles provided via an API.2. It coordinates slicing and communication quality control aligned with the activation of computing functions on the UPF.3. It adds the capability to configure communication sessions and computing features in the control interface for the UPF.4. Proof of Concept OverviewThe proof of concept was conducted by deploying 3GPP-compliant mobile core network on Amazon Web Services (AWS). This network was managed under Nokia's product, a Network as Code platform designed for API management and routing, as defined in GSMA Open Gateway and Linux Foundation CAMARA projects. Within this mobile core network, a new control function was introduced to handle the mobile core network, enabling it to configure communication routes to the ISAP platform in response to computing service activation requests received via the Network as Code platform. An integrated control mechanism was implemented on a container platform equipped with accelerators*7 such as DPUs and GPUs. This mechanism simultaneously activates both communication and computing services when a computing service startup request is issued.During the demonstration, the team verified that mobile connectivity can be provided in response to CAMARA API-based computing service startup requests, confirming the feasibility of on-demand computing services for mobile devices in a practical setting. Additionally, an AI-powered video analysis application was operated within this environment and by linking the computing services with the mobile network to reduce data exchange latency and jitter between devices and servers, it was confirmed that the accuracy rate—57% under conventional architectures—improved to 90%, reaching the performance limit of the AI model.5. Role of each companyNTT: Conducts overall architecture and system design and plans the demonstration, researches and prototypes the Inclusive Core and ISAP, and provides on-premise / cloud demonstration environments.NTT DOCOMO, INC.: Leverages its expertise in global standard specifications for mobile communication systems and leads discussions on methods for mobile network quality and routing control in this demonstration.Nokia Corporation: Offers 3GPP-compliant Core SaaS on the cloud and provides the Network as Code API management platform, compliant with GSMA Open Gateway and CAMARA.6. OutlookNTT and DOCOMO will continue to explore In-Network Computing capabilities with the aim of enabling computing services that work seamlessly with mobile networks in the 6G era. This will involve progressing technical studies and the implementation of solutions requiring high stability and low latency. Going forward, in partnership with Nokia, NTT and DOCOMO plan to expand their collaboration with telecom operators, network equipment and device manufacturers, cloud providers, and service operators. The goal is to advance INC research and development in order to facilitate service deployment, while also contributing to global standardization discussions scheduled for this year, including those led by 3GPP covering 6G architecture this year.(1) A technical concept whereby application-layer processing is delegated to data transfer functions within the network. This approach reduces latency and device power consumption, while delivering high-performance, feature-rich services. By offloading information processing to network-based devices such as switches, it also alleviates the load on terminals.(2) A network architecture proposed by NTT for the 6G/IOWN era. It enables various forms of convergence and cooperation over the network, thereby facilitating the fusion of computing and networking required by next-generation use cases such as AI-integrated communications and cyber-physical systems. For more details, refer to New windowhttps://www.rd.ntt/ns/inclusivecore/whitepaper_ver1.html (only available in Japanese)(3) A GSMA project aimed at establishing common carrier APIs for exposing carrier network functionalities. As of 2024, 62 mobile network operators are participating, working toward the global commercialization of these emerging carrier APIs.(4) An open-source project under the Linux Foundation that develops common carrier API specifications, enabling applications developers to access carrier network function worldwide regardless of region or operator.(5) As an In-Network Computing platform, ISAP intermediates the information processing required by services running on terminals and in the cloud. By rapidly synchronizing and coordinating both, it orchestrates a cascading processing environment on network-based hardware that is tailored to each communication context and service environment. This enables users to enjoy flexible service experiences without being limited by their devices or network conditions and allows service providers to reach a broader user base.(6) A component of the 5G network that handles data transfer, traffic routing, and other related functions.(7) Refers to hardware or software that enhances computing performance. In this demonstration, “accelerators” specifically refer to hardware accelerators such as Data Processing Units (DPUs) and Graphics Processing Units (GPUs).About NTTNTT contributes to a sustainable society through the power of innovation. We are a leading global technology company providing services to consumers and businesses as a mobile operator, infrastructure, networks, applications, and consulting provider. Our offerings include digital business consulting, managed application services, workplace and cloud solutions, data center and edge computing, all supported by our deep global industry expertise. We are over $93B in revenue and 330,000 employees, with $3.6B in annual R&D investments. Our operations span across 80+ countries and regions, allowing us to serve clients in over 190 of them. We serve over 75% of Fortune Global 100 companies, thousands of other enterprise and government clients and millions of consumers.About NTT DOCOMONTT DOCOMO, Japan's leading mobile operator with over 90 million subscribers, is one of the global leaders in 3G, 4G and 5G mobile network technologies. Under the slogan “Bridging Worlds for Wonder & Happiness,” DOCOMO is actively collaborating with global partners to expand its business scope from mobile services to comprehensive solutions, aiming to deliver unsurpassed value and drive innovation in technology and communications, ultimately to support positive change and advancement in global society.https://www.docomo.ne.jp/english/ Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Space Compass and NTT DOCOMO, INC. jointly announced today that they have successfully completed data connectivity tests between the LTE base station and smartphones using high-altitude platform stations (HAPS)(1) from the stratosphere (altitudes of around 20km) in Laikipia County, Kenya.In this test, a communication demonstration using LTE was carried out between the HAPS flying at altitudes around 20km and 4G device on the ground. The LTE base station was connected to the ground gateway station(2), and a relay technology called non-regenerative relay(3) was used to reflect the radio waves through the communication device mounted on the HAPS flying in the stratosphere and connected to the ground based 4G device on the ground. As a result, a throughput of more than 4.66 Mbps was observed during reception of the radio wave transmitted from the ground gateway station to the 4G device via HAPS (Forward Link).The technology to stabilize the beam center to provide the connectivity coverage at a certain position toward a fixed point on the ground from the HAPS rotating in the stratosphere was implemented. Successful delivery of the reflected radio waves to the 4G equipment was confirmed at the test site in Kenya. This is the world's first successful establishment of wireless communication between a fixed-wing HAPS flying in the stratosphere at altitudes above 18 km and a smartphone on the ground.The fixed-wing HAPS aircraft Zephyr, which is designed, manufactured and operated by AALTO HAPS Limited ("AALTO"), a subsidiary of Airbus Defence and Space, was used for the testing. Zephyr has advanced aviation technology, having achieved a record for the longest flight of HAPS in 2022, with a continuous duration of 64 days.Based on the results obtained through test activities, Space Compass and NTT DOCOMO will continue to work towards our HAPS service's targeted entry-into service in 2026, and research and develop a space-based radio access network (RAN) as an NTN, with HAPS serving as key components to support ultra-wide mobile communication services in air, sea and space.The project is part of the Innovative ICT Fund Projects for Beyond 5G/6G, known as Beyond 5G, established by the National Institute of Information and Communications Technology (NICT), which envisions a society where connectivity is assured over the air, sea, and space regardless of user location. (JPJ012368C07702)Takaaki Sato, Senior Executive Vice President and Representative Member of the Board of Directors of NTT DOCOMO, said: "We are delighted about the successful connectivity test of HAPS in Kenya. This achievement marks a significant step forward in shaping the future of mobile communications. By combining long-duration stratospheric flights with DOCOMO's wireless technology, we aim to not only enhance disaster response and expand coverage areas but also to accelerate the delivery of innovative HAPS services that offer unprecedented value."Shigehiro Hori, Co-Chief Executive Officer of Space Compass Corporation, commented: "We are dedicated to working towards the commercialization of our HAPS service in 2026, and the success of this trial marks a significant step forward in achieving this goal. With this important milestone, we will continue to conduct testing and accelerate the development of our HAPS service. We are confident that the future of HAPS holds great potential, and we invite everyone to look forward to what's to come."Hughes Boulnois, Chief Executive Officer of AALTO, said: "This connectivity demonstration is a world-first for HAPS that underpins the capabilities of Zephyr when operating in the stratosphere. Alongside NTT DOCOMO and Space Compass, we have created a strong and complementary partnership that will pave the way for commercial services to begin in the stratosphere from 2026. We are now working with our Japanese partners in accelerating the roadmap for our technology development and services, utilising Zephyr as a game-changing platform for connectivity and Earth observation."(1) Abbreviation for High-Altitude Platform Station. It refers to an unmanned aerial vehicle capable of flying in the stratosphere at an altitude of about 20 km for a few days to several months without landing. The platform is equipped with relay devices, and it can cover areas with a diameter of 100 to 200 km (depending on the design of the aircraft). This technology is being explored for areas that have been difficult to cover, such as the air and seas, as well as rural and mountainous regions where are not economically viable for coverage.(2) A ground station which relays communication between the HAPS and the terrestrial communication network.(3) A communication system where the base station equipment is installed on the ground rather than onboard the HAPS, and the communication device (payload) on the HAPS acts as a relay, reflecting signals received from the ground. In contrast, when base station equipment is installed on the HAPS, it is called a regenerative relay system.About Space Compass CorporationSpace Compass is a joint venture company between NTT, Japanese Information and Communications Technology (ICT) leader, and SKY Perfect JSAT Corporation, Asia's largest satellite operator. We will launch a Space Integrated Computing Network to aid the realization of a sustainable society. For more information, visit our corporate website, https://space-compass.com/en/This project is one of the initiatives of space business brand under NTT Group's "NTT C89" and SKY Perfect JSAT's "JSAT".About NTT DOCOMONTT DOCOMO, Japan's leading mobile operator with over 90 million subscribers, is one of the global leaders in 3G, 4G and 5G mobile network technologies.Under the slogan "Bridging Worlds for Wonder & Happiness," DOCOMO is actively collaborating with global partners to expand its business scope from mobile services to comprehensive solutions, aiming to deliver unsurpassed value and drive innovation in technology and communications, ultimately to support positive change and advancement in global society.https://www.docomo.ne.jp/english/ Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - TOPPAN Inc. and NTT DOCOMO, Inc. announced today that they have signed a basic agreement that will allow them to jointly develop groundbreaking communication services for the forthcoming 6G era.TOPPAN is drawing on its expertise in information processing and computer graphics to deliver a wide variety of metaverse services. Concurrently, DOCOMO is spearheading development of next-generation communication technologies with its FEEL TECH platform, designed to extend human sensory experiences through networks, offering entirely new value for the 6G era.Under the terms of this agreement, TOPPAN will integrate its metaverse and advanced expression capabilities with DOCOMO's FEEL TECH platform. The two companies will subsequently collaborate in the development and provision of services in the fields of education, skill transmission, and online shopping.The first step in the process will be the integration of FEEL TECH with TOPPAN's metaverse app Metapa, which features educational content for museums designed for interactive learning. Development discussions will commence in April 2025. By incorporating FEEL TECH's sensory sharing capabilities into Metapa, both companies aim to develop next-generation content that will allow users to experience the texture of materials and tactile sensations of artists, enhancing art education through direct interaction.Going forward, TOPPAN and DOCOMO will remain dedicated to advancing efforts to deliver next-generation services that surprise and delight customers, using FEEL TECH. Copyright 2025 JCN Newswire via SeaPRwire.com.

Kawasaki and Tokyo, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Rakuten Mobile, Japan’s newest and most modern mobile network, today announced it will begin deploying base stations utilizing radio units (RU) developed by Fujitsu Limited, as it accelerates the expansion of its 5G (Sub6) network area in 2025.Leveraging its expertise in building a fully virtualized, cloud-native mobile network based on Open RAN standards in Japan, Rakuten Mobile will continue to rapidly deploy 5G Sub6 base stations and expand its coverage area. Fujitsu, through its compact and energy-efficient RU, will support Rakuten Mobile’s rollout of 5G commercial services and contribute to the further global adoption of Open RAN.The RU model to be used by Rakuten Mobile, 44R21, adopts the O-RAN specifications established by the O-RAN ALLIANCE – a worldwide community promoting the development of Open RAN specifications. The RU facilitates communication between the base station's distributed unit (DU) and centralized unit (CU) via a fronthaul interface (1). It has a proven track record of interoperability with equipment from various domestic and international vendors, enabling telecommunications carriers to diversify their equipment choices and mitigate supply chain risks. Additionally, using Fujitsu’s proprietary technology, the radio units are designed to be compact, lightweight and energy-efficient, thereby contributing to leaner space requirements and lower network operation costs.The RU 44R21 base model will be showcased at MWC Barcelona 2025, the world’s largest connectivity exhibition, held in Barcelona, Spain, from March 3 to 6, 2025.Going forward, Rakuten Mobile will use its pioneering virtualization network technology and existing base station infrastructure to reduce lead times from construction to operation, ensuring cost-efficient deployments of base stations. Additionally, Rakuten Symphony will work together with Fujitsu to discuss future collaborations, aiming to drive the global rollout of these units and accelerate the worldwide adoption of Open RAN technology.Sharad Sriwastawa, co-CEO and CTO of Rakuten Mobile, commented, "We are excited to partner with Fujitsu to accelerate the rollout of high-performance, energy-efficient 5G base stations. This collaboration will enable us to deliver exceptional mobile services to even more of our customers."Masaaki Moribayashi, Corporate Executive Officer and SEVP, Network Business and Special Assignment of Fujitsu Limited, commented, "Fujitsu’s focus has been to develop an innovative wireless platform that is compact, lightweight, and energy-efficient. In addition to this wireless device that complies with O-RAN standard specifications, Fujitsu will support Rakuten Mobile in building a flexible and efficient network, leveraging its extensive experience in O-RAN connectivity."(1) Fronthaul refers to the network that connects the control equipment and radio units that make up a base station.Product names, service names, and other names mentioned in this press release are generally trademarks or registered trademarks of their respective companies. Trademark symbols such as (TM) and (R) may be omitted in this press release.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.About Rakuten MobileRakuten Mobile, Inc. is a Rakuten Group company responsible for mobile communications, centered on its mobile network operator (MNO) business. Through continuous innovation and the deployment of advanced technology, Rakuten Mobile aims to redefine expectations in the mobile communications industry in order to provide appealing and convenient services for diverse customer needs.Press ContactsRakuten Mobile, Inc.Corporate Communications DepartmentE-mail: global-pr@mail.rakuten.comFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

KAWASAKI, Japan, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced the launch of the Fujitsu Network 1FINITY™ P300 800G ZR/ZR+ coherent pluggable transceiver, an open, high-performance and sustainable key component for optical networking solutions. The transceivers, globally available from the second half of 2025, are compatible with third-party routers, Fujitsu’s Edge Networking portfolio, or in 1FINITY T-series transponder applications, offering flexible deployment options to optimize performance, cost, and power consumption according to the needs of network owners.Featuring the latest 3nm digital signal processor (DSP) semiconductor technology, in addition to pluggable support built-in to the Virtuora® network control solution, the transceivers enable high-performance operation with 30% power per bit reduction and lower costs versus previous pluggable generations. Being made in Japan, the P300 800G coherent pluggable offers high-quality precision components and supply chain resiliency. Compliant with open optical networking standards OIF ZR and Open ROADM MSA, the P-series portfolio will offer a future evolution path to data rates of 1.6 terabits per second (Tbps) and beyond.The 1FINITY P300 will be exhibited at the Fujitsu booth at MWC Barcelona 2025, the world's largest connectivity exhibition, held in Barcelona, Spain, from March 3rd to 6th and at OFC 2025 in San Francisco, California from April 1st to 3rd, 2025.With a majority of today’s businesses relying on Artificial Intelligence (AI) and cloud workloads, rising data demands are driving the need for greater speed, capacity and flexibility throughout telecommunications and data center networks. The 1FINITY P300 enables next-generation data center interconnect (DCI), metro, regional, and long-haul transport network owners to address these challenges sustainably and cost-effectively. Fujitsu’s new P-series coherent pluggables are the latest addition to the 1FINITY Ultra Optical System, a hyper-reliable optical portfolio delivering extreme performance and scalability, including currently available 400G ZR/ZR+ pluggable offerings.The 1FINITY P300 is equipped with ECC (Error Checking and Correcting) to automatically correct memory errors and other issues. Additionally, it features two firmware modules for redundancy, allowing continuous operation by switching to the backup firmware in case of a failure.When combined with the Virtuora Network Control portfolio, the 1FINITY P300 host element simplifies the planning, design, and deployment of multi-domain, multi-vendor optical and packet-optical networks, including IPoDWDM. Featuring industry-leading open optical control, design, and automation, it offers an end-to-end network management solution. Future updates to the Virtuora Network Control portfolio will also include pluggable management capabilities for use with third-party routers that support open optical networking. Virtuora software streamlines operational complexity, reduces time to issue resolution, and enhances both network availability and profitability.Fujitsu’s Commitment to the Sustainable Development Goals (SDGs)The Sustainable Development Goals (SDGs) adopted by the United Nations in 2015 represent a set of common goals to be achieved worldwide by 2030.Fujitsu’s purpose — “to make the world more sustainable by building trust in society through innovation” — is a promise to contribute to the vision of a better future empowered by the SDGs.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

SINGAPORE, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has developed and commercialized software for virtualized radio access network (vRAN) base stations. The company aims to provide this software to telecommunications carriers in Japan and internationally, and to deploy more than 50,000 vRAN base stations by fiscal 2026.vRAN is a system that will serve as the foundation for the development of network technologies in the future, including further enhancement of 5G services, optimization and streamlining of operational costs, flexible network design, accelerated area deployment, and collaboration with the Innovative Optical and Wireless Network (IOWN®) concept proposed by NTT. This is expected to facilitate the development and introduction of new technologies through Open RAN, and promote innovation while reducing power consumption.NEC's vRAN achieves carrier-grade network quality that complies with the specifications defined by the O-RAN ALLIANCE (*1). In addition, because it complies with open interface specifications, it is guaranteed to work in conjunction with equipment from different vendors and cloud environments. By using this software, it is possible to achieve a RAN configuration that is optimal for the specifications required by telecommunications carriers. In addition, it uses a fully containerized architecture and is based on 5G hardware base station technology and knowledge that is cloud-native, has a proven track record of large-scale commercial use, and it is compatible with cutting-edge general-purpose servers. Furthermore, it uses Qualcomm Technologies' inline accelerator, the Qualcomm Dragonwing X100, to speed up processing, and achieves the high speed and large capacity communications that are characteristic of 5G.NEC has already deployed a 5G core network (5GC, *2) that uses virtualization technology, and the commercialization of this software for vRAN will enable the construction of a total cloud-native 5G network from the core to the RAN. This will make it possible to provide a high-quality 5G network that can flexibly respond to diverse service requirements.Furthermore, by utilizing this software, resource reallocation through virtualization is possible, enabling as much as a 65% reduction in total device power consumption when compared to existing 5G base station equipment (*3).In addition, NEC has developed a Near Real-time RAN Intelligent Controller (Near-RT RIC) to enhance the functionality of vRAN. This enables dynamic customization of RAN operation in response to diversifying service demands, and enables functional expansion such as quality improvement, SLA guarantees, and power saving (*4). Moreover, when combined with NEC's solutions for advanced network operation management, the construction time for mobile infrastructure can be reduced by approximately 70% compared to conventional methods, enabling large-scale commercial deployment of 5G networks in a short period of time."NEC is excited to announce the commercialization of our vRAN software, which will play a critical role in shaping the future of network technologies," said Takashi Sato, Corporate Senior Vice President at NEC. "Our vRAN solution not only adheres to strict O-RAN ALLIANCE specifications but also leverages open interfaces and a fully containerized architecture to ensure optimal integration with multi-vendor and cloud environments.""We are very pleased to see our strong collaboration with NEC moving forward with commercial deployment of the Virtualized Distributed Unit (vDU) using the Qualcomm Dragonwing X100 accelerator card," said Gerardo Giaretta, VP & GM of 5G RAN Infrastructure, Qualcomm Technologies, Inc. "This collaboration demonstrates our commitment to delivering high-performance, energy-efficient and cost-effective 5G solutions that meet the evolving needs of network operators around the world."Going forward, NEC will continue to work towards providing high-performance 5G networks that are geared towards 5G Advanced and 6G, as well as networks with high scalability and flexibility that can respond to diversifying service requirements.(1) O-RAN ALLIANCE:An international industry organization that promotes standardization with the aim of realizing open and scalable next-generation wireless access networks, including 5G.(2)5G core (5GC)A mobile core network system that accommodates 5G wireless.(3)Based on NEC's evaluation criteria.(4)Press release: NEC Develops Near Real-time RIC for High Performance 5G vRAN www.nec.com/en/press/202502/global_20250221_02.htmlAbout NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) and Mitsubishi Heavy Industries Machinery Systems, Ltd. (MHI-MS), a part of MHI Group will participate in Japan's first trial project for autonomous trucks, to be conducted on a section of the Shin-Tomei Expressway (between Surugawan-Numazu SA/SIC and Hamamatsu SA/SIC) from March 3 by the Road Bureau of Japan's Ministry of Land, Infrastructure, Transport and Tourism (MLIT), the National Institute for Land and Infrastructure Management (NILIM), and Central Nippon Expressway Company Limited (NEXCO Central).(Note1) MHI-MS has developed and delivered the "Merging Support Information System" that will provide data to support merging during the trial project. This system allows autonomous trucks to ascertain the status of traffic on the main highway well before reaching the acceleration lane, allowing them sufficient time to adjust their speed to ensure safe and smooth merging.The Merging Support Information System is a mechanism for "Cooperative Vehicle/Infrastructure System," an important function of autonomous driving assistance infrastructure, allowing vehicles to operate safely at the junction to the main highway, one of the most challenging situations for autonomous vehicles. MHI-MS developed and delivered a vehicle detection sensor system and roadside processing unit. Information on vehicles traveling on the main highway is obtained from sensors placed along the roadway, and transmitted through the roadside processing unit to trucks attempting to merge onto the main highway, supporting safe and smooth merging. Specifically, since the status of vehicles traveling on the main highway can be ascertained before entering the acceleration lane, the trucks are able to determine a target merging point well in advance and adjust their merging speed, reducing the risk of impeding the vehicles traveling on the main highway. In addition, the information provided by the system can be received by non-autonomous vehicles that have a dedicated receiver, such as ETC 2.0, which allows drivers to use a variety of information services in addition to toll collection, and ITS Connect, which allows vehicles to obtain information on surrounding conditions to support driving assistance through direct communication between vehicles.This trial will be conducted by designating a priority lane for autonomous vehicles during late night hours, and operating autonomous trucks on public roads. The verification of the Merging Support Information System, one of the components of the trial, will be conducted by confirming whether the information provided by the roadside unit can be received appropriately. The Japanese government has implemented the "Digital Lifeline Development Plan," which aims to enhance the safety of autonomous driving, and establish an environment for efficient operation.(Note2) This demonstration experiment is part of that effort.MHI Group has developed sensing and communication technologies through toll collection and ETC systems provided in Japan and overseas, and believes that these technologies can be applied to autonomous driving support infrastructure. The Company also took part in the Cooperative Vehicle/Infrastructure System Demonstration Experiment conducted by NEXCO Central in June 2024 on a section of the Shin-Tomei Expressway that has not yet been put into service,(Note3) and the results obtained from that experiment have been applied to the Merging Support Information System. As various services that make full use of CASE technologies(Note4) are being applied more broadly for road traffic, MHI Group, in addition to sensors and other vehicle functions, will support the development of infrastructure to provide roadway-to-vehicle information, and contribute to the establishment of highly safe and convenient next-generation mobility.(1) For more information on the trial for autonomous trucks, see the following press release from MLIT.https://www.mlit.go.jp/report/press/road01_hh_001884.html (Japanese)(2) For more information on the Digital Lifeline Development Plan, see the following press release from METI.https://www.meti.go.jp/policy/mono_info_service/digital_architecture/lifeline_portal/index.html(Japanese)(3) For more information on MHI Group’s participation in the Cooperative Vehicle/Infrastructure System Demonstration Experiment, see the following press release.https://www.mhi.com/news/22100502.html(4) "CASE" is an acronym derived from the words "connected," "autonomous," "shared" and "electric." It refers to the current technological trend in the automotive industry to create next-generation mobility services offering outstanding safety and convenience.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today the launch of the new nutritional drink “Chocola BB® Nightwell” (designated quasi-drug product), a nutritional drink to help recovery from the accumulated fatigue of the day during sleep, on Monday, March 3. The productbelongs to the Chocola BB brand, which supports people’s beauty and health, and will be available at pharmacy and drugstores throughout Japan.Chocola BB Nightwell contains eight active ingredients, including vitamin B2, which supports fatmetabolism and converts it into energy, and glycine, which improves sleep quality associated with poornutrition, as well as herbal medicines (Crataegus oxyacantha and Citrus unshiu peel). With a grapefruit flavor, Chocola BB Nightwell is easy to drink, low in calories (5.1 kcal per bottle), and caffeine-free, allowing consumption before bedtime. By promoting fatigue recovery during sleep, Chocola BB Nightwell supports a refreshed start to the day.Since the launch of Chocola BB tablets in 1952, the Chocola BB brand has been offering products forover 70 years to address various skin and fatigue symptoms, in line with the needs of each era. The current Chocola BB drink lineup consists of designated quasi-drugs for fatigue care, including “ChocolaBB® Light” for daily fatigue, “Chocola BB® Royal 2” for severe fatigue, and “Chocola BB® Hyper” for low vitality.By marketing the Chocola BB series of products, Eisai is committed to addressing the diverse needswithin fatigue care, and supporting the beauty and wellness of even more people.Please refer to the product’s website for details about Chocola BB Nightwell (Japanese only) www.eisai.jp/products/chocola/chocola_bb_nightwellFOr more information, visit https://www.eisai.com/news/2025/news202514.html. Media Inquiries:Public Relations Department, Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2025 JCN Newswire via SeaPRwire.com.